Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Frontiers in Cellular and Infection Microbiology
|
July 13, 2018
Biomarkers of Cutaneous Leishmaniasis
Fariborz Bahrami, Ali M Harandi, Sima Rafati
Journal of Virology
|
December 28, 2002
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection
Ali M Harandi, Kristina Eriksson, Jan Holmgren
Vaccine
|
May 20, 2015
Molecular signatures of vaccine adjuvants
Thorunn Olafsdottir, Madelene Lindqvist, Ali M Harandi
Antiviral Research
|
February 16, 2008
Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88
Sara Tengvall, Derek O'Hagan, Ali M Harandi
Vaccine
|
January 13, 2010
Vaccine adjuvants: a priority for vaccine research
Ali M Harandi, Donata Medaglini, Robin J Shattock, et al.
Expert Review of Vaccines
|
March 3, 2009
Vaccine adjuvants: scientific challenges and strategic initiatives
Ali M Harandi, Gwyn Davies, Ole F Olesen
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2009
The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection
Madelene Lindqvist, Josefine Persson, Karolina Thörn, et al.
The Journal of General Virology
|
March 21, 2001
Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice
Ali M Harandi, Bo Svennerholm, Jan Holmgren, et al.
Frontiers in Immunology
|
August 29, 2024
Editorial: Novel adjuvant systems that generate pathogen specific T cell responses following immunization for infectious disease vaccine formulations
Amanda M Burkhardt, Szu-Wen Wang, Ali M Harandi
Journal of Reproductive Immunology
|
October 19, 2005
CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice
Sara Tengvall, Agnetha Josefsson, Jan Holmgren, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Frontiers in Cellular and Infection Microbiology
|
July 13, 2018
Biomarkers of Cutaneous Leishmaniasis
Fariborz Bahrami, Ali M Harandi, Sima Rafati
Journal of Virology
|
December 28, 2002
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection
Ali M Harandi, Kristina Eriksson, Jan Holmgren
Vaccine
|
May 20, 2015
Molecular signatures of vaccine adjuvants
Thorunn Olafsdottir, Madelene Lindqvist, Ali M Harandi
Antiviral Research
|
February 16, 2008
Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88
Sara Tengvall, Derek O'Hagan, Ali M Harandi
Vaccine
|
January 13, 2010
Vaccine adjuvants: a priority for vaccine research
Ali M Harandi, Donata Medaglini, Robin J Shattock, et al.
Expert Review of Vaccines
|
March 3, 2009
Vaccine adjuvants: scientific challenges and strategic initiatives
Ali M Harandi, Gwyn Davies, Ole F Olesen
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2009
The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection
Madelene Lindqvist, Josefine Persson, Karolina Thörn, et al.
The Journal of General Virology
|
March 21, 2001
Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice
Ali M Harandi, Bo Svennerholm, Jan Holmgren, et al.
Frontiers in Immunology
|
August 29, 2024
Editorial: Novel adjuvant systems that generate pathogen specific T cell responses following immunization for infectious disease vaccine formulations
Amanda M Burkhardt, Szu-Wen Wang, Ali M Harandi
Journal of Reproductive Immunology
|
October 19, 2005
CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice
Sara Tengvall, Agnetha Josefsson, Jan Holmgren, et al.
Page
of 8